Sylvester Karl P, Patey Richard A, Broughton Simon, Rafferty Gerrard F, Rees David, Thein Swee Lay, Greenough Anne
Division of Asthma, Allergy and Lung Biology, King's College London, United Kingdom.
Pediatr Pulmonol. 2007 Feb;42(2):103-6. doi: 10.1002/ppul.20430.
Acute chest syndrome (ACS) is an important cause of mortality and morbidity in children with sickle cell disease (SCD). An association between asthma and ACS has been reported. Our aims were to determine whether asthma was more common in SCD children than controls and the relationship of the timing of the SCD children's first ACS episode to a diagnosis of asthma. One hundred and sixty-five SCD children median age 8.2 (range 0.3-17.3) years and 151 similar ethnic origin and aged controls were prospectively recruited into the study and a detailed history was taken from all of the children to determine if they were taking anti-asthma medication. The medical records of the SCD children were examined to assess whether they had an ACS episode, the age this episode occurred and when any diagnosis of asthma had been made. A similar proportion of the SCD children and controls were taking anti-asthma medication (7% and 9%). Thirty-three SCD children had at least one ACS episode. More of the children who had an ACS compared to those who had not were taking anti-asthma medication (P = 0.02). The ACS children had been diagnosed as asthmatic at a median of 3.5 (range 0.5-7) years prior to their first ACS episode. In conclusion, these results suggest asthma exacerbations may predispose to ACS episodes.
急性胸综合征(ACS)是镰状细胞病(SCD)患儿死亡和发病的重要原因。已有报道称哮喘与ACS之间存在关联。我们的目的是确定哮喘在SCD患儿中是否比对照组更常见,以及SCD患儿首次ACS发作时间与哮喘诊断之间的关系。165名中位年龄为8.2岁(范围0.3 - 17.3岁)的SCD患儿和151名种族背景相似且年龄相仿的对照组儿童被前瞻性纳入研究,并收集了所有儿童的详细病史以确定他们是否正在服用抗哮喘药物。检查了SCD患儿的病历,以评估他们是否有ACS发作、发作时的年龄以及何时被诊断为哮喘。服用抗哮喘药物的SCD患儿和对照组儿童比例相似(分别为7%和9%)。33名SCD患儿至少有一次ACS发作。与未发作ACS的患儿相比,发作ACS的患儿中更多人正在服用抗哮喘药物(P = 0.02)。ACS患儿在首次ACS发作前中位3.5年(范围0.5 - 7年)被诊断为哮喘。总之,这些结果表明哮喘加重可能易引发ACS发作。